Hiv protease inhibitors

Details Hiv protease inhibitors Hiv protease inhibitors

C - Chemistry, Metallurgy

07

D

C07D 495/04 (2006.01) A61K 31/165 (2006.01) A61K 31/495 (2006.01) C07C 323/60 (2006.01) C07D 211/62 (2006.01) C07D 213/56 (2006.01) C07D 213/81 (2006.01) C07D 215/48 (2006.01) C07D 217/26 (2006.01) C07D 295/205 (2006.01) C07D 401/06 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2268709

HIV protease inhibitors, obtainable by chemical synthesis inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.

Affiliated with

Also associated with

Rating

Hiv protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1768625